Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Chesler

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Cell Reports|January 10, 2026
Exploiting the polypharmacology of alectinib for synergistic RNA splicing disruption with RBM39 degradersYurui Ma, Evon Poon, Chenchen Jin, et al.
Neoplasia (New York, N.Y.)|May 13, 2025
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imagingGilberto S Almeida, Philippa King, Albert Hallsworth, et al.
Cancer Research|June 10, 2015
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered ImmunityFrancis Mussai, Sharon Egan, Stuart Hunter, et al.
Science Signaling|October 30, 2014
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastomaGanesh Umapathy, Abeer El Wakil, Barbara Witek, et al.
Lab on a Chip|July 14, 2025
Diagnostic technologies for neuroblastomaLeena Khelifa, Yubing Hu, Jennifer Tall, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Cancer Cell|June 25, 2013
Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastomaMarkus Brockmann, Evon Poon, Teeara Berry, et al.
Molecular Cancer Therapeutics|September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivoAmir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.
Cancer Cell|August 10, 2016
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood NeuroblastomaMarkus Brockmann, Evon Poon, Teeara Berry, et al.
Neoplasia (New York, N.Y.)|December 11, 2025
Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-functionFederica Lorenzi, Matthew Shipley, Luke Deane, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Cell Reports|January 10, 2026
Exploiting the polypharmacology of alectinib for synergistic RNA splicing disruption with RBM39 degradersYurui Ma, Evon Poon, Chenchen Jin, et al.
Neoplasia (New York, N.Y.)|May 13, 2025
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imagingGilberto S Almeida, Philippa King, Albert Hallsworth, et al.
Cancer Research|June 10, 2015
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered ImmunityFrancis Mussai, Sharon Egan, Stuart Hunter, et al.
Science Signaling|October 30, 2014
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastomaGanesh Umapathy, Abeer El Wakil, Barbara Witek, et al.
Lab on a Chip|July 14, 2025
Diagnostic technologies for neuroblastomaLeena Khelifa, Yubing Hu, Jennifer Tall, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Cancer Cell|June 25, 2013
Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastomaMarkus Brockmann, Evon Poon, Teeara Berry, et al.
Molecular Cancer Therapeutics|September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivoAmir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.
Cancer Cell|August 10, 2016
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood NeuroblastomaMarkus Brockmann, Evon Poon, Teeara Berry, et al.
Neoplasia (New York, N.Y.)|December 11, 2025
Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-functionFederica Lorenzi, Matthew Shipley, Luke Deane, et al.
Pageof 12